Paradigm Biopharmaceuticals Limited
PBIGF
Other OTC0.13
USD
+0.00
- -
Total Valuation
Paradigm Biopharmaceuticals Limited carries a market capitalization of 54.17M, placing it among publicly traded companies globally.
| Market Cap | 54.17M |
| Enterprise Value | N/A |
Stock Price Statistics
Paradigm Biopharmaceuticals Limited's stock has declined approximately -51.34293% over the past 52 weeks. The 50-day moving average sits at 0.16, while the 200-day moving average is 0.21.
| Beta (5Y) | N/A |
| 52-Week Price Change | -51.34293% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.21 |
| Average Volume (20 Days) | N/A |
Stock Splits
Paradigm Biopharmaceuticals Limited's most recent stock split took place on November 1, 2023 with a 250:257 split ratio.
| Last Split Date | 11/1/2023 |
| Split Ratio | 250:257 |